ADVERTISEMENT

Amruntanjan Healthcare - Positive Growth Outlook: HDFC Securities Retail Research Initiates Coverage

Amruntanjan Healthcare - Positive Growth Outlook: HDFC Securities Retail Research Initiates Coverage

<div class="paragraphs"><p>Range of Amrutanjan Healthcare products. (Source: Company website)</p></div>
Range of Amrutanjan Healthcare products. (Source: Company website)

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

HDFC Securities Retail Research

Amrutanjan Healthcare Ltd. is one of the oldest ayurvedic and over-the-counter Indian brand.

The core focus of the company is to create a niche for itself with a strong portfolio of affordable healthcare, personal and hygiene care products in a highly competitive market dominated by premium brands.

Amrutanjan Pain Balm (Yellow Balm) is the flagship brand of the company; apart from this it has been constantly expanding its product portfolio with a range of pain management products (aromatic balms, creams and sprays for headaches, body aches).

Amrutanjan Healthcare also has presence in premium category products under its sub brand ' roll-on' and has also launched brand 'relief' which caters to congestion related issues (cold rubs, nasal inhalers, lozenzes and cough syrups).

Click on the attachment to read the full report:

HDFC Securities Retail Research Initiating Coverage Amrutanjan Healthcare Ltd.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.